Candidate mechanisms for chemotherapy-induced cognitive changes

Area of Science:

• Neuroscience
• Oncology
• Genetics

Background:

• Chemotherapy-induced cognitive changes, often termed "chemobrain," present a significant challenge for cancer survivors.
• The underlying mechanisms contributing to cognitive impairment after chemotherapy remain largely undetermined.

Purpose of the Study:

• To elucidate potential mechanisms underlying chemotherapy-induced cognitive changes.
• To explore the interplay between genetic predispositions and chemotherapy's effects on cognitive function.

Main Methods:

• This study proposes a theoretical framework integrating genetic risk factors and chemotherapy's impact.
• Candidate mechanisms discussed include genetic predispositions in DNA repair, immune response, and neuroprotective systems.

Main Results:

• Shared genetic factors for cancer and cognitive issues, such as inefficient efflux pumps and DNA repair deficits, may be exacerbated by chemotherapy.
• Chemotherapy may also induce cognitive decline through reduced neural repair capacity and antioxidant defenses, potentially linked to hormonal changes (estrogen, testosterone).

Conclusions:

• A combination of genetic vulnerabilities and chemotherapy's systemic effects likely contributes to cognitive decline.
• Interactions between genetic factors, hormonal modulation, and neural repair capacity may independently or collectively impact cognitive function post-chemotherapy.